The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results